Skip to main content Skip to main navigation menu Skip to site footer

Risk of Malignancy Index 3 (RMI3) Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma used for NACT

Perfoma Risk of Malignancy Index 3 (RMI3) sebagai Prediktor Karsinoma Ovarium Epithelial Stadium Lanjut untuk Pertimbangan Pemberian NACT

Tatit Nurseta
Putu A. Herliawati student
Dhian E. P. Harnandari
Kusworini Handono
Yahya Irwanto
Sutrisno Sutrisno

DOI: https://doi.org/10.32771/inajog.v10i1.1599

Downloads

Download data is not yet available.

FULL TEXT

Published

2022-01-28

Issue

Volume 10 No. 1 January 2022

Section

Research Article

Copyright (c) 2022 Indonesian Journal of Obstetrics and Gynecology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Tatit Nurseta, Yahya Irwanto, Nugrahanti Prasetyorini, Bambang Rahardjo, I Wayan Subage, Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor , Indonesian Journal of Obstetrics and Gynecology: Volume 8 No. 4 October 2020
Tatit Nurseta, Yahya Irwanto, Imelda Imelda, Curcumin Administration on Proliferation and Apoptosis Index in Complete Hydatidiform Mole CellCulture , Indonesian Journal of Obstetrics and Gynecology: Volume. 4, No. 1, January 2016
Tatit Nurseta, Arsana Wijasa, Barlian Sitompul, Impact of Ethinyl Estradiol to Human Telomerase Reverse Transcriptase Activity on Complete Hydatidiform Mole Culture , Indonesian Journal of Obstetrics and Gynecology: Volume. 4, No. 2, April 2016
Yahya Irwanto, Expression of Fas Ligand is Higher in Early Stage Cervical Cancer with Lymph Nodes Metastasis , Indonesian Journal of Obstetrics and Gynecology: Volume. 36, No. 4, October 2012